Attenuation of the Recombinant Human Parainfluenza Virus Type 3 cp45 Candidate Vaccine Virus Is Augmented by Importation of the Respiratory Syncytial Virus cpts530 L Polymerase Mutation-Reference-Cited by-同舟云学术

Attenuation of the Recombinant Human Parainfluenza Virus Type 3 cp45 Candidate Vaccine Virus Is Augmented by Importation of the Respiratory Syncytial Virus cpts530 L Polymerase Mutation

Published:1999-07 Issue:1 Volume:260 Page:125-135
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Skiadopoulos Mario H.,Surman Sonja R.,St. Claire Marisa,Elkins William R.,Collins Peter L.,Murphy Brian R.

Publisher

Elsevier BV

Subject

Virology

Reference42 articles.

1. Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers;Belshe;J. Med. Virol.,1982

2. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse;Bukreyev;J. Virol.,1997

3. Parainfluenza Viruses;Collins,1996

4. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

5. Evaluation of coldadapted and temperature-sensitive mutants of parainfluenza virus type 3 in weanling hamsters;Crookshanks;J. Med. Virol.,1984

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates;PLOS ONE;2020-02-11

2. Respiroviruses: Parainfluenza Virus;Topley & Wilson's Microbiology and Microbial Infections;2010-03-15

3. Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters;Journal of General Virology;2008-07-01

4. Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates;Vaccine;2007-08

5. Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxoviruses;Vaccine;2005-09